These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34997893)

  • 1. The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients.
    Jiang L; Zhou J; Zhang L; Du Y; Jiang M; Xie L; Ma Z; Chen F
    Glycoconj J; 2021 Dec; 38(6):697-707. PubMed ID: 34997893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
    Ma X; An L; Wang Q
    Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes.
    Yuan Y; Li L; Wang X; Zhang P; Wang J; Xiao Y
    Altern Ther Health Med; 2023 May; 29(4):52-56. PubMed ID: 36947659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
    Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
    J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis.
    Cui ZH; Lu XT; Xiao KL; Chen Y; Li HQ
    Curr Med Sci; 2019 Apr; 39(2):250-258. PubMed ID: 31016518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between interleukin-19 concentration and diabetic nephropathy.
    Li L; Jiang XG; Hu JY; Yu ZQ; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
    BMC Nephrol; 2017 Feb; 18(1):65. PubMed ID: 28201997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of the Trace Elements Zinc and Magnesium With Diabetic Nephropathy-Associated Renal Functional Damage in Patients With Type 2 Diabetes Mellitus.
    Feng J; Wang H; Jing Z; Wang Y; Wang W; Jiang Y; Sun W
    Front Med (Lausanne); 2021; 8():626909. PubMed ID: 33859989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Genetic Association and Expressions of Notch-2 /Jagged-1 in Patients with Type 2 Diabetes Mellitus.
    Al-Awaida WJ; Hameed WS; Al Hassany HJ; Al-Dabet MM; Al-Bawareed O; Hadi NR
    Med Arch; 2021 Apr; 75(2):101-108. PubMed ID: 34219868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.
    Chen YL; Qiao YC; Xu Y; Ling W; Pan YH; Huang YC; Geng LJ; Zhao HL; Zhang XX
    Immunol Lett; 2017 Jun; 186():52-58. PubMed ID: 28414180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
    Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
    Koleva-Georgieva DN; Sivkova NP; Terzieva D
    Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
    Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
    PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Diagnostic Utility of Serum Omentin 1 and IL-6 in Early Stages of Diabetic Nephropathy.
    Devi S; Sahu S; Behera KK; Sahoo D; Priyadarshini N
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL; Wu J; Guo LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.